KR20140090456A - Method for preparing red ginseng extract with enhanced sugar content and sweetness by using freezing point extraction - Google Patents
Method for preparing red ginseng extract with enhanced sugar content and sweetness by using freezing point extraction Download PDFInfo
- Publication number
- KR20140090456A KR20140090456A KR1020130002542A KR20130002542A KR20140090456A KR 20140090456 A KR20140090456 A KR 20140090456A KR 1020130002542 A KR1020130002542 A KR 1020130002542A KR 20130002542 A KR20130002542 A KR 20130002542A KR 20140090456 A KR20140090456 A KR 20140090456A
- Authority
- KR
- South Korea
- Prior art keywords
- red ginseng
- ginseng extract
- sugar
- content
- extraction
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 91
- 239000000284 extract Substances 0.000 title claims abstract description 64
- 238000000605 extraction Methods 0.000 title claims abstract description 61
- 235000000346 sugar Nutrition 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 39
- 230000008014 freezing Effects 0.000 title abstract description 12
- 238000007710 freezing Methods 0.000 title abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 20
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 12
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 claims description 10
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 claims description 10
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 8
- 229930091371 Fructose Natural products 0.000 claims description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 7
- 229930182490 saponin Natural products 0.000 claims description 7
- 150000007949 saponins Chemical class 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 239000005715 Fructose Substances 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 claims 3
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 150000002337 glycosamines Chemical class 0.000 abstract description 3
- 235000019658 bitter taste Nutrition 0.000 abstract description 2
- 229930182494 ginsenoside Natural products 0.000 description 14
- 229940089161 ginsenoside Drugs 0.000 description 13
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 229960004793 sucrose Drugs 0.000 description 7
- 238000003809 water extraction Methods 0.000 description 7
- 229960002737 fructose Drugs 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000013681 dietary sucrose Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 2
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 2
- AGBCLJAHARWNLA-DQUQINEDSA-N Ginsenoside Rg2 Natural products O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@@](C)(O)CCC=C(C)C)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O AGBCLJAHARWNLA-DQUQINEDSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000000105 evaporative light scattering detection Methods 0.000 description 2
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 2
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000001474 liquid chromatography-evaporative light scattering detection Methods 0.000 description 2
- 229960002160 maltose Drugs 0.000 description 2
- 239000006199 nebulizer Substances 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- AGBCLJAHARWNLA-UHFFFAOYSA-N (20R)-ginsenoside Rg2 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C3C(C)(C)C(O)CCC3(C)C3C(C4(CCC(C4C(O)C3)C(C)(O)CCC=C(C)C)C)(C)C2)OC(CO)C(O)C1O AGBCLJAHARWNLA-UHFFFAOYSA-N 0.000 description 1
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 1
- RAQNTCRNSXYLAH-RFCGZQMISA-N (20S)-ginsenoside Rh1 Chemical compound O([C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RAQNTCRNSXYLAH-RFCGZQMISA-N 0.000 description 1
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 description 1
- UZIOUZHBUYLDHW-MSJHMJQNSA-N Ginsenoside Rf Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@@H]2[C@](C)([C@@]3(C)[C@H]([C@@H](O)C2)[C@@H]([C@@](O)(CC/C=C(\C)/C)C)CC3)C1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 UZIOUZHBUYLDHW-MSJHMJQNSA-N 0.000 description 1
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 1
- RAQNTCRNSXYLAH-UHFFFAOYSA-N Ginsenoside Rh1 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(C3)C)(C)C1C(O)CC2C1(C)CCC(O)C(C)(C)C1C3OC1OC(CO)C(O)C(O)C1O RAQNTCRNSXYLAH-UHFFFAOYSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000020934 caloric restriction Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 1
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 1
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- UZIOUZHBUYLDHW-XUBRWZAZSA-N ginsenoside Rf Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZIOUZHBUYLDHW-XUBRWZAZSA-N 0.000 description 1
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 1
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- JURZHOVRCOWZFN-UHFFFAOYSA-N notoginsenoside R1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(COC7OCC(O)C(O)C7O)C(O)C(O)C6O)C JURZHOVRCOWZFN-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Abstract
Description
본 발명은 빙결점 추출법에 의하여 당 함량이 증가하고 감미가 향상된 홍삼 추출물을 제조하는 방법에 관한 것이다.The present invention relates to a method for preparing red ginseng extract having increased sugar content and improved sweetness by freezing point extraction.
홍삼은 예로부터, 피로회복, 면역력 증진, 혈행개선 등의 우수한 효능으로 인하여 많은 사람들이 이용하고 있다. 특히 홍삼의 주요 성분인 사포닌은 인삼의 여러 가지 유효성분 중 주된 약리 작용을 하는 진세노사이드라 불리는 성분으로서, 최근 분리, 분석기술의 발달에 따라 지금까지 30종의 인삼 사포닌의 화학구조가 밝혀졌으며, 현재 연구 결과로 알려진 사포닌 약리작용으로는 항종양작용, 항피로작용, 정신안정작용, 항염증작용, 노화억제작용 등 여러 가지 약리작용을 하는 것으로 보고되고 있다. From ancient times, red ginseng has been used by many people because of its excellent efficacy such as fatigue recovery, immunity enhancement, and improvement of blood circulation. Especially, saponin, which is a major component of red ginseng, is a component called ginsenoside which is the main pharmacological effect of various active ingredients of ginseng. Recently, according to the development of separation and analytical techniques, 30 chemical structures of ginseng saponin have been identified, Saponin pharmacological actions known as the present study are reported to have various pharmacological actions such as antitumor action, anti-fatigue action, mental stabilization action, anti-inflammatory action and aging-inhibiting action.
그러나 이러한 홍삼의 우수한 효능에도 불구하고 홍삼은 특유의 고미를 가지고 있어 이로부터 홍삼 추출물을 제조하는 경우 홍삼 추출물에 고미가 잔류하게 된다. 이러한 홍삼 추출물의 쓴맛으로 인해 홍삼 성분을 함유하는 제품은 전연령층에서 높은 선호도를 보이지 못하고 있다. 기존에는 홍삼의 관능성을 개선하기 위하여 올리고당 또는 엿당과 같은 당류에 홍삼을 침지하거나 첨가하기도 하는데, 이로 인해 당을 과도하게 섭취하게 되어 당뇨 환자나 비만 또는 칼로리를 제한해야 하는 환자에 있어서는 사용이 제한될 수밖에 없으며, 제조 공정에 있어서도 비용 및 시간이 추가로 소모되어 효율성이 떨어질 수 있다. However, in spite of the excellent efficacy of red ginseng, red ginseng has a unique red ginseng, and when it is prepared from red ginseng extract, ginseng remains in red ginseng extract. Due to the bitter taste of these red ginseng extracts, products containing red ginseng have not shown high preference in all ages. Previously, in order to improve the functionality of red ginseng, red ginseng was added or added to saccharides such as oligosaccharides or polysaccharides. As a result, excessive use of sugar would result in excessive use of diabetes, obesity or restriction of caloric restriction In addition, the manufacturing process may be costly and time consuming, which may reduce efficiency.
지금까지 홍삼은 대부분이 고온에서 장시간 추출하여 복용하고 있으나 기능성 또는 기호도를 높이기 위한 추출 온도 및 추출 시간이 정립되지 않았다. 따라서, 어린이나 젊은 세대들에 있어서도 홍삼 제품의 선호도를 높이고 관능성을 개선하면서 홍삼 고유의 약리적인 활성을 유지하기 위한 방법으로 홍삼 특유의 고미를 완화시키는 홍삼 추출 기술 및 제제의 개발이 필요하다.Until now, most of red ginseng has been extracted for a long time at high temperature, but extraction temperature and extraction time for increasing functionality or preference have not been established. Therefore, it is necessary to develop red ginseng extracting technology and formulation to reduce the red ginseng specific ginseng as a method for maintaining the pharmacological activity inherent in red ginseng, while increasing the preference of red ginseng product and improving the sensibility.
본 발명의 목적은 당 함량 증가로 인하여 감미가 향상된 홍삼 추출물을 제조하기 위한 방법을 제공하기 위한 것이다.It is an object of the present invention to provide a method for preparing red ginseng extract having improved sweetness due to an increase in sugar content.
상기 목적을 달성하기 위하여, 본 발명은 홍삼에 추출 용매를 첨가하고 -2 내지 10℃에서 추출하는 단계를 포함하는 당 함량이 증가된 홍삼 추출물의 제조 방법을 제공한다.In order to achieve the above object, the present invention provides a method for preparing red ginseng extract having an increased sugar content, comprising the step of adding an extraction solvent to red ginseng and extracting at -2 to 10 ° C.
본 발명은 또한 상기 제조 방법에 의해 제조된 당 함량이 증가된 홍삼 추출물을 제공한다.The present invention also provides a red ginseng extract having increased sugar content produced by the above-described method.
본 발명의 홍삼 추출물 제조 방법은, 종래의 100℃ 부근의 온도에서 실시하는 열수 추출법에서 벗어나 저온인 -2 내지 10℃에서 추출하는 방법이다.The method of the present invention for extracting red ginseng is a method of extracting at a low temperature of from -2 to 10 캜, apart from the conventional hot water extraction method performed at a temperature of around 100 캜.
상기 추출 온도가 -2 내지 10℃이면 상대적으로 낮은 온도에서도 용출 속도가 빠른 수용성 당을 다량 용출시켜 홍삼 추출물내 당 함량을 증가시킬 수 있다. 그러나 추출 온도가 -2℃ 미만이면, 당이 충분히 용출되기에 낮은 온도일 수 있으며, 추출 온도가 10℃를 초과하면, 홍삼에 함유되어 있는 당이 충분히 용출되기에 필요 이상의 가열온도를 소모하게 되어 경제적이지 않을 뿐만 아니라, 당 이외의 기타 고미 성분들도 용출되어 감미 개선 효과가 떨어지게 되므로 바람직하지 않다.When the extraction temperature is in the range of -2 to 10 ° C, the sugar content in the red ginseng extract can be increased by eluting a large amount of the water-soluble sugar having a fast dissolution rate even at a relatively low temperature. However, if the extraction temperature is less than -2 DEG C, it may be a low temperature for sufficient elution of the sugar, and if the extraction temperature exceeds 10 DEG C, the sugar contained in red ginseng is eluted sufficiently, It is not economical, and other gummy ingredients other than sugars are also eluted and the effect of improving the sweetness deteriorates, which is not preferable.
본 발명이 바람직한 구현예에 있어서, 상기 홍삼은 직접 재배하거나 시판되는 것을 사용할 수 있고 특별히 제한되지 않는다. 예를 들어, 홍미삼 또는 동체를 사용할 수 있으며, 홍미삼은 대미, 중미 및 세미 모두 사용할 수 있다. 본 발명의 추출 방법에 있어서, 상기 추출 용매는 물, 탄소수 1 내지 4의 알코올 및 이들의 혼합 용매로 구성된 군으로부터 선택되는 것이 바람직하고, 물, 에탄올 또는 이들의 혼합 용매인 것이 보다 바람직하나 이에 한정되지 않는다. 상기 혼합 용매는 물:에탄올이 3:7 내지 7:3의 부피비로 혼합될 수 있으나 특별히 이에 한정되는 것은 아니다.In a preferred embodiment of the present invention, the red ginseng can be cultivated directly or commercially available, and is not particularly limited. For example, red ginseng or fusiform body can be used, and red ginseng can be used in both the United States, Central America and the United States. In the extraction method of the present invention, the extraction solvent is preferably selected from the group consisting of water, an alcohol having 1 to 4 carbon atoms and a mixed solvent thereof, more preferably water, ethanol or a mixed solvent thereof, It does not. The mixed solvent may be mixed in a volume ratio of water: ethanol of 3: 7 to 7: 3, but is not limited thereto.
상기 추출시 추출 시간은 1 내지 71시간인 것이 바람직하다. 추출 시간이 1시간 미만인 경우에는 홍삼으로부터 충분한 양의 당을 추출하기 어렵고, 71시간을 초과하면 추출 시간의 증가에 따른 당 추출 정도에 증가가 나타나지 않는다. 특히, 12시간 이내에 당 성분이 추출물 중 50% 이상의 함량으로 추출되는 것이 가능하여 6 내지 12시간 동안 추출하는 것이 더욱 바람직하나 이에 한정되지 않는다.The extraction time for the extraction is preferably 1 to 71 hours. When the extraction time is less than 1 hour, it is difficult to extract a sufficient amount of sugar from red ginseng. When the extraction time exceeds 71 hours, the sugar extraction does not increase with the extraction time. In particular, it is possible to extract the sugar component in an amount of 50% or more of the extract within 12 hours, and it is more preferable to extract for 6 to 12 hours, but not limited thereto.
본 발명의 방법에 있어서, 상기 당은 유리당인 포도당(glucose), 과당(fructose), 자당(sucrose), 맥아당(maltose) 및 AFG(Arginyl-fructosyl-glucose)로 구성된 군으로부터 선택되는 어느 하나 이상인 것이 바람직하고, 특히 맥아당 및/또는 AFG인 것이 보다 바람직하나 이에 한정되지 않는다. 상기 맥아당은 다른 당들에 비해 상대적으로 감미도가 우수한 당이고, 상기 AFG는 비만과 당뇨 증세 개선 및 혈액순환기계 질병의 개선 등에 유효한 것으로 알려진 아미노당이다.In the method of the present invention, the sugar may be any one or more selected from the group consisting of glucose, fructose, sucrose, maltose and AFG (arginyl-fructosyl-glucose) More preferably maltose and / or AFG, but is not limited thereto. The maltose is a sugar having a relatively high degree of sweetness as compared with other sugars. The AFG is an amino sugar known to be effective for improving obesity, diabetes and blood circulatory diseases.
본 발명의 바람직한 구현예에 있어서, 본 발명의 방법에 따라 제조된 홍삼 추출물의 고형분 100 중량부에 대하여, 홍삼 추출물의 당 함량은 50 내지 99.9 중량부일 수 있고, 이중 맥아당은 20 내지 60 중량부일 수 있으며, AFG는 10 내지 30 중량부인 것이 바람직하나 이에 한정되지 않는다. 이는 20℃ 부근에서 추출한 경우에 비해 50 ~ 115% 높은 함량이고, 100℃ 부근에서 열수 추출한 경우에 비해 250% 증가한 당 함량을 나타내는 것이다.In a preferred embodiment of the present invention, the sugar content of the red ginseng extract may be 50 to 99.9 parts by weight, and the maltose may be 20 to 60 parts by weight based on 100 parts by weight of the solid content of the red ginseng extract prepared according to the method of the present invention And AFG is preferably 10 to 30 parts by weight, but is not limited thereto. This is 50 ~ 115% higher than that extracted at around 20 ℃ and 250% higher than the case of hot water extraction at around 100 ℃.
본 발명의 바람직한 구현에에 따르면, 상기 제조 방법은 추출물을 수득한 이후에 이를 농축하는 단계를 추가로 포함할 수 있다. 농축 방법은 당업계에 공지된 통상의 방법에 따라 실시될 수 있으며, 바람직하게는 감압농축을 실시할 수 있다. 농축에 의해 고형분 함량이 50 내지 70%가 되도록 하는 것이 적합하나 이에 한정되는 것은 아니다. 또, 농축 이후에는 추출액을 동결건조하여 분말화할 수 있다.According to a preferred embodiment of the present invention, the method further comprises the step of obtaining the extract and then concentrating it. The concentration method can be carried out according to a conventional method known in the art, and preferably, the concentration under reduced pressure can be carried out. It is preferable, but not limited, to have a solid content of 50 to 70% by concentration. After concentration, the extract can be lyophilized and pulverized.
상기와 같이 제조된 본 발명의 홍삼 추출물은 기존의 열수추출법으로 제조된 추출물과 비교하여 진세노사이드 함량에는 차이가 없으나 유기당 및 아미노당과 같은 당의 함량이 증가함으로써 홍삼의 유효성분이 유지되면서 특유의 고미가 제거되고 감미가 향상될 수 있다.The red ginseng extract prepared according to the present invention has no difference in ginsenoside content compared to the extract prepared by the conventional hot water extraction method, but the content of the sugar such as organic sugar and amino sugar is increased, so that the effective ingredient of red ginseng is maintained, And the sweetness can be improved and the sweetness can be improved.
본 발명의 바람직한 구현예에 따르면, 본 발명자들은 감미가 우수한 홍삼 추출물을 제조함에 있어서, 용출 속도가 상대적으로 빠른 수용성 당을 과량 포함하는 홍삼 추출물을 수득하기 위해, 홍삼에 7배수의 추출 용매를 처리하여 -2 내지 20℃의 온도에서 6 내지 71시간 동안 추출하였다(도 1 참조). 그 결과, -2 내지 10℃의 온도에서 추출한 경우, 12시간 이내에 추출물내 당 함량이 50% 이상을 나타내었고, 이는 20℃의 온도에서 추출한 경우에 비해 50~115% 높은 것임을 확인하였다(표 1, 도 2 및 도 3 참조). 추출 용매에 따라서는 당 함량의 유의적인 차이가 없는 것으로 나타났다(표 3 및 도 4 참조). 또, 추출된 당들 중에서 빙결점 온도에서 상대적으로 용출율이 높은 맥아당이 가장 높은 비율로 존재하였으며, 아미노당인 AFG가 그 다음으로 높은 비율로 존재하는 것을 확인하였다(표 5 참조). 홍삼의 유효성분인 진세노사이드의 경우에는 -2 내지 20℃의 추출 온도 및 추출 용매에 비의존적으로 함량의 유의적인 차이가 없는 것으로 나타났으나(표 2 및 표 4 참조), 본 발명의 빙결점 추출과 열수 추출에 의한 각각의 추출물내 진세노사이드 함량을 비교한 결과, 프로토파낙사디올계(PD) 사포닌 대 프로토파낙사트리올계(PT) 사포닌의 함량비(PD/PT)가 약 1.3인 것으로 확인되어 열수 추출에 의한 추출물의 약 2.5 보다 작은 것으로 나타남으로써(표 6 참조), PD 대 PT의 비율이 조절되는 것을 확인하였다.According to a preferred embodiment of the present invention, in order to obtain a red ginseng extract containing an excessive amount of a soluble sugar having a relatively fast dissolution rate in preparing a red ginseng extract having excellent sweetness, And extracted at a temperature of -2 to 20 DEG C for 6 to 71 hours (see Fig. 1). As a result, it was confirmed that when extracted at a temperature of -2 to 10 ° C, the sugar content in the extract was more than 50% within 12 hours, which was 50 to 115% higher than that extracted at a temperature of 20 ° C , Figs. 2 and 3). There was no significant difference in sugar content depending on the extraction solvent (see Table 3 and FIG. 4). Among the extracted sugars, maltose having a relatively high dissolution rate was present at the highest ratio at the freezing point temperature, and it was confirmed that AFG having the amino group was present at the next highest ratio (see Table 5). In the case of ginsenoside, the active ingredient of red ginseng, there was no significant difference in the extraction temperature between -2 and 20 ° C and the extraction solvent independent (see Tables 2 and 4) (PD / PT) ratio of protopanaxadiol (PD) saponin to protopanaxyl triol (PT) saponin was found to be about 1.3 (See Table 6), it was confirmed that the ratio of PD to PT was controlled.
따라서, 본 발명에서는 고함량의 당을 함유하는 홍삼 추출물 제조시 -2 내지 10℃ 온도에서의 빙결점 추출하는 것이 가장 최적의 조건임을 확립하였으므로, 상기와 같은 제조 방법은 당 함량이 증가되고 감미가 향상된 홍삼 추출물을 제조하는데 유용하게 이용될 수 있으며, 이와 같이 제조된 홍삼 추출물은 홍삼 고유의 당을 이용하여 고미가 감소하고 감미를 개선한 홍삼 제품에 유용하게 이용될 수 있다.Therefore, in the present invention, it was established that extraction of freezing point at -2 to 10 ° C was the most optimal condition in the production of a red ginseng extract containing a high content of sugar. Therefore, The red ginseng extract thus prepared can be usefully used in red ginseng products in which the sweetness is reduced and the sweetness is improved by using the sugar of the red ginseng.
본 발명에 따른 홍삼 추출물 제조 방법은 열처리 및/또는 산처리 등의 추출 공정 없이도, 간단한 공정으로 당 함량이 높은 홍삼 추출물을 제조할 수 있으므로, 별도로 효소나 당류와 같은 첨가제를 첨가하지 않으면서 홍삼 추출물의 고미 및 감미를 획기적으로 개선시킬 수 있는 효과가 있다.Since the red ginseng extract according to the present invention can produce the red ginseng extract having a high sugar content by a simple process without any heat treatment such as heat treatment and / or acid treatment, it is possible to produce red ginseng extract without addition of additives such as enzymes and saccharides. It is possible to remarkably improve the sweetness and sweetness of the food.
도 1은 본 발명의 홍삼 추출물의 제조 공정도를 나타낸 것이다.
도 2는 추출 온도 및 시간에 따른 홍삼 추출물의 당 함량 변화를 나타낸 것이다.
도 3은 추출 온도 및 시간에 따른 홍삼 추출물의 맥아당 함량 변화를 나타낸 것이다.
도 4는 추출 용매에 따른 홍삼 추출물의 상태를 나타낸 것이다.FIG. 1 shows a process for producing the red ginseng extract of the present invention.
FIG. 2 shows changes in sugar content of red ginseng extract according to extraction temperature and time.
FIG. 3 shows changes in maltose content of red ginseng extract according to extraction temperature and time.
4 shows the state of the red ginseng extract according to the extraction solvent.
이하, 본 발명을 하기 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail by the following examples.
단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 의해 한정되는 것은 아니다.
However, the following examples are illustrative of the present invention, and the contents of the present invention are not limited by the following examples.
<< 실시예Example 1> 1> 빙결점Freezing point 추출법에 의한 홍삼 추출물의 제조 Preparation of red ginseng extract by extraction method
한국인삼공사 6년근 홍삼을 재료로 사용하여 당이 고함유된 홍삼 추출물을 제조를 위하여, 홍삼에 7배수(W/W)의 증류수, 50% 에탄올 또는 70% 에탄올을 가한 후 -2 ~ 20℃에서 6 ~ 71시간 동안 정치 추출하였다. 추출액은 6,000 rpm에서 원심분리하여 그 상층액을 배스(bath) 온도 55 ~ 65℃에서 감압농축하여 홍삼 농축액을 제조하였다. 정확한 제조 수율과 진세노사이드 함량을 계산하기 위해 농축액의 수분 함량은 36%로 보정하여 홍삼농축액을 제조하였다(도 1).
Korean Red Ginseng Corporation Red ginseng extract was prepared by adding 6% (W / W) of distilled water, 50% ethanol or 70% ethanol to red ginseng, For 6 to 71 hours. The extract was centrifuged at 6,000 rpm and the supernatant was concentrated under reduced pressure at a bath temperature of 55 to 65 ° C to prepare a red ginseng concentrate. In order to calculate the exact production yield and ginsenoside content, the water content of the concentrate was adjusted to 36% to prepare a red ginseng concentrate (Fig. 1).
<< 실시예Example 2> 추출 온도 및 시간에 따른 홍삼 추출물의 성분 분석 2> Analysis of Components of Red Ginseng Extracts by Temperature and Time of Extraction
상기 실시예 1에 기재된 바와 같은 추출 온도 및 추출 시간에 따른 홍삼 추출물내 당 함량 및 진세노사이드 함량을 분석하였다.The sugar content and ginsenoside content in red ginseng extract according to the extraction temperature and extraction time as described in Example 1 above were analyzed.
<2-1> 추출 온도 및 시간에 따른 홍삼 추출물의 당 함량 측정<2-1> Determination of sugar content of red ginseng extract by extraction temperature and time
추출 온도 및 시간에 따른 홍삼 추출물내 당 함량의 변화를 확인하기 위하여, 추출 온도 -2, 10 및 20℃ 각각에 대하여 6 ~ 71시간의 추출 시간에 따른 각각의 당 함량을 측정하였다. 구체적으로, 상기 실시예 1에서 최종적으로 얻은 홍삼 농축액 0.5 g을 증류수 25 ㎖에 녹인 후 0.45 ㎛ 주사기용 필터로 여과하여 시험용 샘플을 제조하였다. 제조된 샘플을 HPLC-ELSD(High Performance Liquid Chromatography-Evaporative Light Scattering Detector) 방법으로 포도당(glucose), 과당(frucose), 자당(sucrose) 및 맥아당(maltose)의 함량을 각각 측정하였다. 포동당, 과당, 자당 및 맥아당의 표준액은 Sigma 사에서 구입하여 사용하였으며, 고성능액체크로마토그래피를 이용하여 표준 검량 곡선을 작성한 후, 시험용 샘플의 당 함량을 측정하였다. 당 성분의 HPLC-ELSD(Aliance 2695, Waters/Alltech 2420 ELSD) 분석 조건은 하기와 같았다. HPLC 컬럼은 Carbohydrate ES 5u(4.6×250 mm)를 사용하였으며, 이동상은 H2O(A)와 CH3CN(B)을 75:25의 비율로 하였다. 컬럼 온도는 25℃, 유속은 분당 0.7 ㎖로 하였으며 검출기 조건은 온도 90℃, N2 가스 압력은 30 psi, Nebulizer control heater 레벨은 80%로 설정하여 분석하였다.To determine the changes of sugar content in red ginseng extract according to extraction temperature and time, the sugar content of each of the extracts at the extraction temperature of 2, 10, and 20 ℃ was measured according to the extraction time of 6 to 71 hours. Specifically, 0.5 g of the red ginseng condensate finally obtained in Example 1 was dissolved in 25 ml of distilled water, and the solution was filtered through a 0.45 탆 syringe filter to prepare a test sample. Glucose, frucose, sucrose and maltose contents were measured by HPLC-ELSD (High Performance Liquid Chromatography-Evaporative Light Scattering Detector) method. The standard solutions of poured sugar, fructose, sucrose and maltose were purchased from Sigma, and a standard calibration curve was prepared using high performance liquid chromatography, and then the sugar content of the test sample was measured. HPLC-ELSD (Aliance 2695, Waters / Alltech 2420 ELSD) analysis conditions of the sugar components were as follows. Carbohydrate ES 5u (4.6 × 250 mm) was used as the HPLC column, and H 2 O (A) and CH 3 CN (B) were used as the mobile phase at a ratio of 75:25. Column temperature 25 ℃, the flow rate was 0.7 per minute to a temperature condition detector ㎖ 90 ℃, N 2 gas pressure was 30 psi, Nebulizer heater control levels were set to 80%.
그 결과, 추출 온도 -2 ~ 10℃, 추출 시간 12시간 이내의 조건에서 홍삼 추출물의 당 함량이 50% 이상을 나타내었으며, 이는 추출 온도 20℃의 동일 추출 시간과 비교하였을 때보다 50 ~ 115% 증가된 값으로 확인되었다. 또한, 상대적으로 감미도가 우수한 맥아당(maltose)의 경우, -2 ~ 10℃의 저온에서 높은 함량을 나타냈으며, 이는 빙결점 온도에서 상대적으로 용출율이 높은 맥아당이 다량 용출된 결과인 것을 알 수 있었다(표 1, 도 2 및 도 3).As a result, the sugar content of red ginseng extract was over 50% under the condition of extraction temperature of -2 ~ 10 ℃ and extraction time of 12 hours, which was 50 ~ 115% And increased value. In addition, maltose having a relatively high sweetness showed a high content at a low temperature of -2 to 10 ° C, which is a result of a large elution of maltose having a relatively high dissolution rate at the freezing point temperature ( Table 1, Fig. 2 and Fig. 3).
(℃)Extraction temperature
(° C)
(시간)Extraction time
(time)
(glucose)glucose
(glucose)
(Fructose)fruit sugar
(Fructose)
(Sucrose)saccharose
(Sucrose)
(Maltose)Maltose
(Maltose)
<2-2> 추출 온도 및 시간에 따른 <2-2> Extraction temperature and time 진세노사이드Gin Senocide 함량 측정 Content measurement
추출 온도 및 시간에 따른 홍삼 추출물의 진세노사이드 함량 변화를 확인하기 위하여, 추출 온도 -2, 10 및 20℃ 각각에 대하여 6 ~ 71시간의 추출 시간에 따른 각각의 진세노사이드 Rg1 및 Rb1의 함량을 측정하였다. 구체적으로, 상기 실시예 1에서 최종적으로 얻은 홍삼 농축액 2 g을 증류수 50 ㎖에 녹인 후 0.45 ㎛ 주사기용 필터로 여과하여 시험용 샘플을 제조하였다. 제조된 샘플을 HPLC-UVD(High Performance Liquid Chromatography-Ultraviolet Detector) 방법으로 진세노사이드 Rg1, Re, Rf, Rh1, Rg2s, Rb1, Rc, Rb2, Rd, Rg3s 및 Rg3r의 함량을 측정하였다. 진세노사이드 Rg1, Re, Rf, Rh1, Rg2s, Rb1, Rc, Rb2, Rd, Rg3s 및 Rg3r의 표준액은 Chromadex 사에서 구입하여 사용하였으며, 고성능액체크로마토그래피를 이용하여 표준 검량 곡선을 작성한 후, 시험용 샘플의 진세노사이드 함량을 측정하였다. 진세노사이드 성분의 HPLC-UVD(Aliance 2695, Waters/Waters 2996) 분석 조건은 하기와 같았다. HPLC 컬럼은 discovery C18(4.6×250 mm, 5 ㎛)을 사용하였으며, 이동상은 H2O(A)와 CH3CN(B)을 사용하여 용매 B 비율을 20%에서 20%(10분), 32%(40분), 50%(55분), 65%(70분), 90%(71분), 90%(80분)으로 순차적으로 변화시켜 주고 마지막으로 다시 20%(81분)로 조절하였다. 컬럼 온도는 35℃, 유속은 분당 1.6 ㎖, UV 파장은 203 nm로 설정하여 분석하였다.To determine the ginsenoside content of red ginseng extract by extraction temperature and time, the content of each ginsenoside Rg1 and Rb1 at extraction temperatures of 2, 10, and 20 ℃ for 6 to 71 hours Were measured. Specifically, 2 g of the red ginseng concentrate finally obtained in Example 1 was dissolved in 50 ml of distilled water, and the solution was filtered through a 0.45 탆 syringe filter to prepare a test sample. The content of ginsenosides Rg1, Re, Rf, Rh1, Rg2s, Rb1, Rc, Rb2, Rd, Rg3s and Rg3r was measured by a HPLC-UVD method. The standard solutions of ginsenosides Rg1, Re, Rf, Rh1, Rg2s, Rb1, Rc, Rb2, Rd, Rg3s and Rg3r were purchased from Chromadex and used to prepare standard calibration curves using high performance liquid chromatography, The ginsenoside content of the sample was measured. HPLC-UVD (Aliance 2695, Waters / Waters 2996) analysis conditions of the ginsenoside components were as follows. The solvent B ratio was changed from 20% to 20% (10 min) using H 2 O (A) and CH 3 CN (B), using the discovery C18 (4.6 × 250 mm, (80 minutes), followed by 32% (40 minutes), 50% (55 minutes), 65% (70 minutes), 90% (71 minutes) and 90% Respectively. The column temperature was set at 35 ° C, the flow rate was set at 1.6 ml per minute, and the UV wavelength was set at 203 nm.
그 결과, 추출 온도 및 시간에 따른 진세노사이드 Rg1 및 Rb1의 함량은 다소 변화되었으나 그 차이는 유의적이지 않았다. 이를 통해 홍삼추출물내 진세노사이드의 함량은 추출 조건에 영향을 거의 받지 않는 것을 알 수 있었다(표 2).As a result, the contents of ginsenosides Rg1 and Rb1 were slightly changed with the extraction temperature and time, but the difference was not significant. The content of ginsenosides in red ginseng extract was not affected by extraction conditions (Table 2).
(℃)Extraction temperature
(° C)
(시간)Extraction time
(time)
<< 실시예Example 3> 추출 용매에 따른 홍삼 추출물의 당 함량 및 3> Sugar Content of Red Ginseng Extracts by Extraction Solvents 진세노사이드Gin Senocide 함량 분석 Content analysis
상기 실시예 2에 기재된 방법을 이용하여 상기 실시예 1에서 제조한 각각의 추출 용매별 홍삼 추출물의 당 함량 및 진세노사이드 함량을 분석하였다. 이때, 상기 홍삼 추출물은 증류수, 50% 에탄올 또는 70% 에탄올을 추출 용매로 이용하고 20℃에서 4일간 추출을 실시한 것을 대상으로 성분 분석을 실시하였다.The sugar content and ginsenoside content of the red ginseng extracts of each of the extracting solvents prepared in Example 1 were analyzed using the method described in Example 2 above. At this time, the red ginseng extract was subjected to component analysis using distilled water, 50% ethanol or 70% ethanol as an extraction solvent and extracting at 20 ° C for 4 days.
그 결과, 추출 용매에 따른 홍삼 추출물내 당 함량 변화는 거의 없는 것으로 나타났다(표 3). 진세노사이드 함량은 70% 에탄올 추출물이 가장 높게 측정되었으나 감미도 측면에서 특이한 특성이 없었으며, 수율은 증류수로 추출하였을 경우가 가장 높았으나(표 4), 20℃에서 추출을 실시한 결과, 추출 3일째부터 악취 및 미생물 성장이 확인되어 상업적으로 이용하는데 어려움이 있는 것으로 확인되었다(도 4).As a result, there was almost no change in sugar content in red ginseng extract depending on the extraction solvent (Table 3). The highest concentration of ginsenoside was 70% ethanol extract, but no specificity in terms of sweetness, and the yield was the highest when distilled water was extracted (Table 4). As a result of extraction at 20 ° C, And it was confirmed that there was a difficulty in commercial use because odor and microbial growth were confirmed (Fig. 4).
<< 실시예Example 4> 4> 빙결점Freezing point 추출법 및 Extraction method and 열수Heat number 추출법에 따른 홍삼 추출물의 당 함량, The sugar content of red ginseng extract, 진세노사이드Gin Senocide 및 And AFGAFG 함량 분석 Content analysis
본 발명의 빙결점 추출법에 의해 제조된 홍삼 추출물과, 종래의 열수 추출법에 의해 제조된 홍삼 추출물내 당 함량 및 진세노사이드 함량을 비교하기 위하여, 상기 실시예 1에서 제조한 본 발명의 홍삼 추출물과 함께, 대조구로서 기존의 열수 추출법에 의해 제조된 홍삼 추출물을 이용하였다. 본 발명의 홍삼추출물은 추출 용매로 증류수를 사용하여 -2 또는 10℃에서 12시간 동안 추출하였고, 상기 열수 추출법에 의해 제조된 홍삼 추출물은 87℃에서 8시간씩 7회 추출하여 추출액을 6,000 rpm에서 원심분리한 후 상층액을 배스 온도 65℃에서 감압농축하여 홍삼 농축액을 제조하였다. 정확한 제조 수율과 진세노사이드 함량을 계산하기 위해 농축액의 수분함량은 36%로 보정하였다.In order to compare the sugar content and the ginsenoside content of the red ginseng extract prepared by the freezing point extraction method of the present invention and the red ginseng extract prepared by the conventional hot water extraction method, the ginseng extract of the present invention prepared in Example 1 The red ginseng extract prepared by the conventional hot water extraction method was used as a control. The red ginseng extract of the present invention was extracted with distilled water as an extraction solvent at -2 or 10 ° C. for 12 hours. The red ginseng extract prepared by the hot water extraction method was extracted 7 times at 87 ° C. for 8 hours and the extract was extracted at 6,000 rpm After centrifugation, the supernatant was concentrated under reduced pressure at a bath temperature of 65 ° C to prepare a red ginseng concentrate. The water content of the concentrate was corrected to 36% to calculate the exact production yield and ginsenoside content.
또한, 빙결점 추출법 및 열수 추출법에 따른 홍삼 추출물의 AFG 함량을 측정하기 위하여, 상기 방법에 따라 최종적으로 얻은 각각의 홍삼 농축액 0.1 g을 증류수 10 ㎖에 녹인 후 0.45 ㎛ 주사기용 필터로 여과하여 시험용 샘플을 제조하였다. 제조된 샘플을 HPLC-ELSD(High Performance Liquid Chromatography-Evaporative Light Scattering Detector) 방법으로 AFG의 함량을 측정하였다. AFG의 표준액은 (주)한국인삼공사에서 순도 98% 이상으로 분리하여 사용하였으며, 고성능액체크로마토그래피를 이용하여 표준 검량 곡선을 작성한 후, 시험용 샘플의 AFG 함량을 측정하였다. AFG 성분의 HPLC-ELSD (Aliance 2695, Waters/Alltech 24200 ELSD) 분석 조건은 하기와 같았다. HPLC 컬럼은 Hypercarb(2.1×100 mm, Thermo 사)를 사용하였으며, 이동상은 7 mM 퍼플루오로펜타노익(perfluoropentanoic) 수용액과 CH3CN(B)을 사용하여 용매 B 비율을 0%에서 15%(5분), 15%(11분), 50%(11.5분), 50%(12.5분)으로 순차적으로 변화시켜 주고 마지막으로 다시 0%(13분)으로 조절하였다. 컬럼 온도는 60℃, 유속은 분당 0.4 ㎖로 하였으며 검출기 조건은 온도 75℃, N2 가스 압력은 30 psi, Nebulizer control heater 레벨은 80%으로 설정하여 분석하였다.Also, in order to measure the AFG content of the red ginseng extract according to the freezing point extraction method and the hot water extraction method, 0.1 g of each red ginseng concentrate finally obtained according to the above method was dissolved in 10 ml of distilled water, and the solution was filtered with a 0.45 쨉 m syringe filter, . The content of AFG was measured by HPLC-ELSD (High Performance Liquid Chromatography-Evaporative Light Scattering Detector) method. The standard solution of AFG was separated from Korean Ginseng Co., Ltd. with a purity of 98% or more. A standard calibration curve was prepared using high performance liquid chromatography, and the AFG content of the test sample was measured. HPLC-ELSD (Aliance 2695, Waters / Alltech 24200 ELSD) analysis conditions of AFG components were as follows. The HPLC column used was Hypercarb (2.1 × 100 mm, Thermo). The mobile phase contained solvent B ratios from 0% to 15% (w / w) using a 7 mM aqueous perfluoropentanoic solution and CH 3 CN 5 minutes), 15% (11 minutes), 50% (11.5 minutes), and 50% (12.5 minutes), and finally to 0% (13 minutes). Column temperature 60 ℃, the flow rate was 0.4 per minute to a temperature condition detector ㎖ 75 ℃, N 2 gas pressure was analyzed by 30 psi, Nebulizer heater control level is set to 80%.
그 결과, 본 발명에 따른 홍삼 추출물은 대조구와 비교하여 당 함량이 2.5배 증가하였으며, 그 중 감미도가 우수한 맥아당과 기능성 당일 AFG 함량 증가가 가장 크게 나타났다. 본 발명의 홍삼 추출물은 구성 당 중의 대부분이 맥아당으로 이루어져있으며, 고형분 100% 기준으로 50% 이상이 맥아당으로 구성된 것으로 확인되었다(표 5). 또한, 진세노사이드 Rg1 및 Rb1의 함량은 두 실험군에서 큰 차이를 나타내지 않았다(표 6).As a result, the sugar content of the red ginseng extract according to the present invention was increased 2.5 times as compared with that of the control, and the increase in the AFG content of the maltose and the functional sugar of the highest sweetness was the largest. The red ginseng extract of the present invention was found to contain maltose in a majority of the constituent sugars, and more than 50% of maltose in 100% of the solid content (Table 5). In addition, the content of ginsenosides Rg1 and Rb1 did not differ significantly between the two experimental groups (Table 6).
(87℃)Hydrothermal extraction method
(87 DEG C)
* PT: 프로토파낙사트리올, 진세노사이드 Rg1, Re, Rf, Rh1 및 Rg2의 합* PT: the sum of protopanaxyl triol, ginsenoside Rg1, Re, Rf, Rh1 and Rg2
* PD: 프로토파낙사디올, 진세노사이드 Rb1, Rb2, Rc, Rd 및 Rg3의 합* PD: The sum of protopanaxadiol, ginsenoside Rb1, Rb2, Rc, Rd and Rg3
Claims (12)
상기 추출 용매는 물, 탄소수 1 ~ 4의 저급 알코올 및 이들의 혼합 용매로 구성된 군으로부터 선택되는 어느 하나인 당 함량이 증가된 홍삼 추출물의 제조 방법The method according to claim 1,
Wherein the extraction solvent is selected from the group consisting of water, a lower alcohol having 1 to 4 carbon atoms, and a mixed solvent thereof, wherein the sugar content is increased
상기 추출은 1 내지 71시간 동안 추출하는 것인 당 함량이 증가된 홍삼 추출물의 제조 방법.The method according to claim 1,
Wherein the extraction is performed for 1 to 71 hours, wherein the sugar content is increased.
상기 추출은 6 내지 12시간 동안 추출하는 것인 당 함량이 증가된 홍삼 추출물의 제조 방법.The method of claim 3,
Wherein the extraction is carried out for 6 to 12 hours, wherein the sugar content is increased.
상기 당은 포도당(glucose), 과당(fructose), 자당(sucrose), 맥아당(maltose) 및 AFG(Arginyl-fructosyl-glucose)로 구성된 군으로부터 선택되는 어느 하나 이상인 것인 당 함량이 증가된 홍삼 추출물의 제조 방법.The method according to claim 1,
Wherein the sugar is at least one selected from the group consisting of glucose, fructose, sucrose, maltose and AFG (arginyl-fructosyl-glucose). Gt;
상기 당은 맥아당 및 AFG로 구성된 군으로부터 선택되는 어느 하나 이상인 것인 당 함량이 증가된 홍삼 추출물의 제조 방법.The method of claim 5,
Wherein the sugar is at least one selected from the group consisting of maltose and AFG.
상기 홍삼 추출물은 고형분 100 중량부에 대하여 50 내지 99.9 중량부의 당을 함유하는 것인 당 함량이 증가된 홍삼 추출물의 제조 방법.The method according to claim 1,
Wherein the red ginseng extract contains 50 to 99.9 parts by weight of sugar per 100 parts by weight of the solid content, wherein the sugar content is increased.
상기 홍삼 추출물은 고형분 100 중량부에 대하여 20 내지 60 중량부의 맥아당을 함유하는 것인 당 함량이 증가된 홍삼 추출물의 제조 방법.The method according to claim 1,
Wherein the red ginseng extract contains maltose in an amount of 20 to 60 parts by weight based on 100 parts by weight of the solid content.
상기 홍삼 추출물은 고형분 100 중량부에 대하여 10 내지 30 중량부의 AFG를 함유하는 것인 당 함량이 증가된 홍삼 추출물의 제조 방법.The method according to claim 1,
Wherein the red ginseng extract contains 10 to 30 parts by weight of AFG based on 100 parts by weight of the solid content, wherein the sugar content is increased.
상기 홍삼 추출물은 고미가 제거되고 감미가 향상된 것인 당 함량이 증가된 홍삼 추출물의 제조 방법.The method according to claim 1,
Wherein the red ginseng extract has a reduced sweetness and an improved sweetness.
상기 홍삼 추출물의 프로토파낙사디올계(protopanaxadiol, PD) 사포닌 대 프로토파낙사트리올계(protopanaxatriol, PT) 사포닌의 함량비(PD/PT)는 1.0 ~ 1.5인 것인 당 함량이 증가된 홍삼 추출물의 제조 방법.The method according to claim 1,
The content ratio of protopanaxadiol (PD) saponin to protopanaxatriol (PT) saponin (PD / PT) of the red ginseng extract was 1.0 to 1.5, and the content of the red ginseng extract Gt;
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130002542A KR101443487B1 (en) | 2013-01-09 | 2013-01-09 | Method for preparing red ginseng extract with enhanced sugar content and sweetness by using freezing point extraction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130002542A KR101443487B1 (en) | 2013-01-09 | 2013-01-09 | Method for preparing red ginseng extract with enhanced sugar content and sweetness by using freezing point extraction |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140090456A true KR20140090456A (en) | 2014-07-17 |
KR101443487B1 KR101443487B1 (en) | 2014-09-22 |
Family
ID=51738077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130002542A KR101443487B1 (en) | 2013-01-09 | 2013-01-09 | Method for preparing red ginseng extract with enhanced sugar content and sweetness by using freezing point extraction |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101443487B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102279749B1 (en) | 2020-10-30 | 2021-07-20 | 주식회사 지바이오 | Manufacturing method of glycation products from red ginseng containing Compound K |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040081932A (en) * | 2003-03-17 | 2004-09-23 | 설혜영 | Quick-Extraction & Condensed Liquid Enlargement from the steamed Red |
KR20090022456A (en) * | 2007-08-30 | 2009-03-04 | 주식회사 케이티앤지 | Methods for preparing amino acid extract from red ginseng |
-
2013
- 2013-01-09 KR KR1020130002542A patent/KR101443487B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR101443487B1 (en) | 2014-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jaitak et al. | An efficient microwave‐assisted extraction process of stevioside and rebaudioside‐A from Stevia rebaudiana (Bertoni) | |
US7037536B2 (en) | α-amylase activity inhibitors | |
JP7334284B2 (en) | Stevia-derived molecules, methods of obtaining such molecules, and uses thereof | |
Jiang et al. | Identification of phenolic compounds in fruits of Ribes stenocarpum Maxim. By UHPLC-QTOF/MS and their hypoglycemic effects in vitro and in vivo | |
Wu et al. | Structural characterization and hepatoprotective effects of polysaccharides from Anoectochilus zhejiangensis | |
CN111793099A (en) | Method for separating hesperidin, neohesperidin, naringin and synephrine from immature bitter orange | |
Zhang et al. | Evaluation of storage period of fresh ginseng for quality improvement of dried and red processed varieties | |
CN104171792A (en) | Enzyme-modified stevia health sugar and preparation method thereof | |
WO2012094752A1 (en) | Processes of purifying steviol glycosides reb c | |
KR101443487B1 (en) | Method for preparing red ginseng extract with enhanced sugar content and sweetness by using freezing point extraction | |
CN106892958B (en) | A kind of exocyclic double bond Ursane triterpene saponin componds and its preparation method and application | |
KR20090022456A (en) | Methods for preparing amino acid extract from red ginseng | |
CN101133833B (en) | Matrimony vine active polyoses producing method | |
Qu et al. | Converting ginsenosides from stems and leaves of Panax notoginseng by microwave processing and improving their anticoagulant and anticancer activities | |
EP3310799B1 (en) | A novel compound (ks 513) isolated from pseudolysimachion rotundum var. subintegrum and the composition comprising the same as an active ingredient for preventing or treating allergy disease, inflammatory disease, asthma or chronic obstructive pulmonary disease | |
KR102167790B1 (en) | Black ginseng extract with increased anti-cancer component contents, method for manufacturing thereof, and anti-cancer composition comprising the same | |
KR20220095075A (en) | Anti-inflammation composition, Health functional food containing the same and Pharmaceutical composition containing the same | |
KR102219193B1 (en) | A composition improving quality of taste comprising allulose | |
KR102411104B1 (en) | Method for producing ginseng concentrate using plate evaporation concentration technology | |
CN109770323A (en) | A kind of preparation method and application of food additives | |
KR102333674B1 (en) | Raw ginseng hydrolysis composition and manufacturing method thereof | |
KR102568259B1 (en) | Platycodon saponin composition | |
KR20190048323A (en) | Ginsenoside composition for treating, improving, or preventing inflammatory disease, and method for preparing the same | |
KR102150116B1 (en) | Black ginseng extract with increased anti-cancer component ginsenoside Mc contents, method for manufacturing thereof, and anti-cancer composition comprising the same | |
CN115260269B (en) | Composition containing ginseng secondary glycoside and aglycone thereof, preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170829 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180904 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20190821 Year of fee payment: 6 |